{"PubmedBookArticle": [], "PubmedArticle": [{"MedlineCitation": {"KeywordList": [], "SpaceFlightMission": [], "InvestigatorList": [], "OtherAbstract": [], "OtherID": [], "CitationSubset": ["IM"], "GeneralNote": [], "PMID": "28614373", "DateCompleted": {"Year": "2017", "Month": "09", "Day": "15"}, "DateRevised": {"Year": "2018", "Month": "11", "Day": "13"}, "Article": {"ArticleDate": [{"Year": "2017", "Month": "06", "Day": "14"}], "Language": ["eng"], "ELocationID": ["e0179218", "10.1371/journal.pone.0179218"], "Journal": {"ISSN": "1932-6203", "JournalIssue": {"Volume": "12", "Issue": "6", "PubDate": {"Year": "2017"}}, "Title": "PloS one", "ISOAbbreviation": "PLoS One"}, "ArticleTitle": "Relationship between microRNA-146a expression and plasma renalase levels in hemodialyzed patients.", "Pagination": {"StartPage": "e0179218", "MedlinePgn": "e0179218"}, "Abstract": {"AbstractText": ["microRNA (miRNA) belongs to the non-coding RNAs family responsible for the regulation of gene expression. Renalase is a protein composed of 342 amino acids, secreted by the kidneys and possibly plays an important role in the regulation of sympathetic tone and blood pressure. The aim of the present study was to investigate plasma renalase concentration, and explore the relationship between miRNA-146a-5p expression and plasma renalase levels in hemodialyzed patients.", "The study population comprised 55 subjects who succumbed to various cardiac events, 27 women and 28 men, aged 65-70 years. The total RNA including miRNA fraction was isolated using QiagenmiRNEasy Serum/Plasma kit according to the manufacturer's protocol. The isolated miRNAs were analyzed using a quantitative polymerase chain reaction (qRT-PCR) technique. The plasma renalase levels were measured using a commercial ELISA kit.", "In the group of patients with high levels of renalase, higher miRNA-146a expression was found, compared with those with low concentration of renalase. Patients with simultaneous low miRNA-146a expression and high level of renalase were confirmed to deliver a significantly longer survival time compared with other patients.", "miRNA-146a and plasma renalase levels were estimated as independent prognostic factors of hemodialyzed patients' survival time. Patients with low miRNA-146a expression demonstrated a significantly longer survival time in contrast to the patients with a high expression level of miRNA-146a. Moreover, a significantly longer survival time was found in patients with high renalase activity compared with patients with low activity of the enzyme."]}, "AuthorList": [{"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Department of Laboratory Diagnostic, Medical University of Lublin, Lublin, Poland."}], "LastName": "Dziedzic", "ForeName": "Marcin", "Initials": "M"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Department of Human Physiology, Medical University of Lublin, Lublin, Poland."}], "LastName": "Powr\u00f3zek", "ForeName": "Tomasz", "Initials": "T"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Department of Nephrology, Medical University of Lublin, Lublin, Poland."}], "LastName": "Or\u0142owska", "ForeName": "Ewelina", "Initials": "E"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Chair and Department of Bromatology, Medical University of Lublin, Lublin, Poland."}], "LastName": "Koch", "ForeName": "Wojciech", "Initials": "W"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Chair and Department of Pharmacognosy with Medicinal Plants Unit, Medical University of Lublin, Lublin, Poland."}], "LastName": "Kukula-Koch", "ForeName": "Wirginia", "Initials": "W"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Department of Experimental and Clinical Pharmacology, Medical University of Lublin, Lublin, Poland."}], "LastName": "Gawe\u0142", "ForeName": "Kinga", "Initials": "K"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Department of Nephrology, Medical University of Lublin, Lublin, Poland."}], "LastName": "Bednarek-Skublewska", "ForeName": "Anna", "Initials": "A"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Department of Human Physiology, Medical University of Lublin, Lublin, Poland."}], "LastName": "Ma\u0142ecka-Massalska", "ForeName": "Teresa", "Initials": "T"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Department of Pneumonology, Oncology and Allergology, Medical University of Lublin, Lublin, Poland."}], "LastName": "Milanowski", "ForeName": "Janusz", "Initials": "J"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Department of Oral Medicine, Medical University of Lublin, Lublin, Poland."}], "LastName": "Petkowicz", "ForeName": "Beata", "Initials": "B"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Department of Laboratory Diagnostic, Medical University of Lublin, Lublin, Poland."}], "LastName": "Solski", "ForeName": "Janusz", "Initials": "J"}], "PublicationTypeList": ["Journal Article"]}, "MedlineJournalInfo": {"Country": "United States", "MedlineTA": "PLoS One", "NlmUniqueID": "101285081", "ISSNLinking": "1932-6203"}, "ChemicalList": [{"RegistryNumber": "0", "NameOfSubstance": "MIRN146 microRNA, human"}, {"RegistryNumber": "0", "NameOfSubstance": "MicroRNAs"}, {"RegistryNumber": "EC 1.4.3.4", "NameOfSubstance": "Monoamine Oxidase"}, {"RegistryNumber": "EC 1.4.3.4.", "NameOfSubstance": "renalase"}], "MeshHeadingList": [{"QualifierName": [], "DescriptorName": "Aged"}, {"QualifierName": [], "DescriptorName": "Aged, 80 and over"}, {"QualifierName": [], "DescriptorName": "Female"}, {"QualifierName": [], "DescriptorName": "Humans"}, {"QualifierName": [], "DescriptorName": "Male"}, {"QualifierName": ["genetics"], "DescriptorName": "MicroRNAs"}, {"QualifierName": ["blood"], "DescriptorName": "Monoamine Oxidase"}, {"QualifierName": ["mortality"], "DescriptorName": "Renal Dialysis"}, {"QualifierName": [], "DescriptorName": "Survival Analysis"}], "CoiStatement": "<b>Competing Interests: </b>The authors have declared that no competing interests exist."}, "PubmedData": {"ReferenceList": [{"ReferenceList": [], "Reference": [{"Citation": "Wilflingseder J, Reindl-Schwaighofer R, Sunzenauer J, Kainz A, Heinzel A, Mayer B\net al.\nMicroRNAs in kidney transplantation. Nephrol Dial Transplant. 2015; 30(6):910\u20137. doi: 10.1093/ndt/gfu280\n", "ArticleIdList": ["10.1093/ndt/gfu280", "PMC4301831", "25170095"]}, {"Citation": "Felekkis K, Touvana E., Stefanou Ch., Deltas C.: microRNAs: a newly described class of encoded molecules that play a role in health and disease. Hippokratia. 2010; 14(4):236\u201340.", "ArticleIdList": ["PMC3031315", "21311629"]}, {"Citation": "Martino F, Lorenzen J, Schmidt J, Schmidt M, Broll M, G\u00f6rzig Y, et al.\nCirculating MicroRNAs Are Not Eliminated by Hemodialysis. PLoS One. 2012; 7(6):e38269\ndoi: 10.1371/journal.pone.0038269\n", "ArticleIdList": ["10.1371/journal.pone.0038269", "PMC3371001", "22715378"]}, {"Citation": "Chen NX, Kiattisunthorn K, O'Neill KD, Chen X, Moorthi RN, Gattone VH, et al.\nDecreased microRNA is involved in the vascular remodeling abnormalities in chronic kidney disease (CKD). PLoS One. 2013; 22;8(5):e64558\ndoi: 10.1371/journal.pone.0064558\n", "ArticleIdList": ["10.1371/journal.pone.0064558", "PMC3661525", "23717629"]}, {"Citation": "Go A.S, Chertow G.M, Fan D, McCulloch C.E, Hsu C.Y. Chronic kidney disease and the risks of death, cardiovascular events, and hospitalization. N Engl J Med\n2004; 352(13):1296\u20131305. doi: 10.1056/NEJMoa041031", "ArticleIdList": ["10.1056/NEJMoa041031", "15385656"]}, {"Citation": "K/DOQI. K/DOQI clinical practice guidelines on hypertension and antihypertensive agents in chronic kidney disease. Am J Kidney Dis. 2004; 43(5/1):S1\u2013290.", "ArticleIdList": ["15114537"]}, {"Citation": "Dziedzic M, Petkowicz B, Bednarek-Skublewska A, Solski J, Buczaj A, Choina P. Relationship between renalase and N-terminal pro-B-type natriuretic peptide (NT pro-BNP) in haemodialysis patients. Ann Agric Environ Med. 2014; 21(1):132\u20135.", "ArticleIdList": ["24738512"]}, {"Citation": "Wang H, Peng W, Shen X, Huang Y, Ouyang X, Dai Y. Circulatinglevels of inflammation-associated miR-155 and endothelial-enriched miR-126 in patients with end-stage renal disease. Braz J MedBiol Res. 2012; 45(12):1308\u201314. doi: 10.1590/S0100-879X2012007500165", "ArticleIdList": ["10.1590/S0100-879X2012007500165", "PMC3854222", "23070235"]}, {"Citation": "Xu J, Li G, Wang P, Velazquez H, Yao X, Li Y, et al.\nRenalase is a novel, soluble monoamine oxidase that regulates cardiac function and blood pressure. J Clin Invest. 2005; 115(5):1275\u20131280. doi: 10.1172/JCI24066", "ArticleIdList": ["10.1172/JCI24066", "PMC1074681", "15841207"]}, {"Citation": "Creemers E.E, Tijsen A.J, Pinto Y.M. Circulating microRNAs: novel biomarkers and extracellular communicators in cardiovascular disease?\nCirc Res. 2012; 110(3):483\u201395. doi: 10.1161/CIRCRESAHA.111.247452\n", "ArticleIdList": ["10.1161/CIRCRESAHA.111.247452", "22302755"]}, {"Citation": "Catalucci D, Gallo P, Condorelli G. MicroRNAs in cardiovascular biology and heart disease. Circ Cardiovasc Genet. 2009; 2(4):402\u20138. doi: 10.1161/CIRCGENETICS.109.857425\n", "ArticleIdList": ["10.1161/CIRCGENETICS.109.857425", "20031613"]}, {"Citation": "Ono K, Kuwabara Y, Han J. MicroRNAs and cardiovascular diseases. FEBS J. 2011; 278(10):1619\u201333. doi: 10.1111/j.1742-4658.2011.08090.x\n", "ArticleIdList": ["10.1111/j.1742-4658.2011.08090.x", "PMC3087823", "21395978"]}, {"Citation": "Buraczynska M, Zukowski P, Buraczynska K, Mozul S, Ksiazek A. Renalase gene polymorphisms in patients with type 2 diabetes, hypertension and stroke. Neuromolecular Med. 2011; 13(4):321\u20137. doi: 10.1007/s12017-011-8158-6\n", "ArticleIdList": ["10.1007/s12017-011-8158-6", "PMC3220827", "21964580"]}, {"Citation": "Farzaneh-Far R, Desir GV, Na B, Schiller NB, Whooley MA. A functional polymorphism in renalase (Glu37Asp) is associated with cardiac hypertrophy, dysfunction, and ischemia: data from the heart and soul study. PLoS One. 2010: 5(10):e13496\ndoi: 10.1371/journal.pone.0013496\n", "ArticleIdList": ["10.1371/journal.pone.0013496", "PMC2958117", "20975995"]}, {"Citation": "Li G, Xu J, Wang P, Velazquez H, Li Y, Wu Y, et al.\nCatecholamines regulate the activity, secretion, and synthesis of renalase. Circulation. 2008; 117(10):1277\u201382. doi: 10.1161/CIRCULATIONAHA.107.732032\n", "ArticleIdList": ["10.1161/CIRCULATIONAHA.107.732032", "18299506"]}, {"Citation": "Wang J, Qi S, Cheng W, Li L, Wang F, Li YZ, et al.\nIdentification, expression and tissue distribution of a renalase homologue from mouse. Mol Biol Rep. 2008; 35(4):613\u201320. doi: 10.1007/s11033-007-9131-1", "ArticleIdList": ["10.1007/s11033-007-9131-1", "17846919"]}, {"Citation": "Stec A, Ksiazek A, Buraczynska M. Rs10887800 renalase gene polymorphism is associated with an increased risk of coronary artery disease in hemodialyzed patients. Int Urol Nephrol. 2016; 48(6):871\u20136. doi: 10.1007/s11255-016-1270-7\n", "ArticleIdList": ["10.1007/s11255-016-1270-7", "PMC4894921", "27023477"]}, {"Citation": "Rutkowski B, et al. Report On The Renal Replacement Therapy In Poland\u2013 2007 Gda\u0144sk. 2009; p.1\u2013122 http://www.nephro-quest.org (access: 17.03. 2014)."}, {"Citation": "Agarwal R, Nissenson AR, Batlle D, Coyne DW, Trout JR, Warnock DG. Prevalence, treatment, and control of hypertension in chronic hemodialysis patients in the United States. Am J Med. 2003; 115(4):291\u20137", "ArticleIdList": ["12967694"]}, {"Citation": "Sarnak MJ, Levey AS. Epidemiology, diagnosis, and management of cardiac disease in chronic renal disease. J Thromb Thrombolysis. 2000; 10(2): 169\u2013180.", "ArticleIdList": ["11005939"]}, {"Citation": "Sch\u00e4rer K, Schmidt KG, Soergel M. Cardiac function and structure in patients with chronic renal failure. Pediatr Nephrol. 1999; 13(9):951\u2013965. doi: 10.1007/s004670050737", "ArticleIdList": ["10.1007/s004670050737", "10603158"]}, {"Citation": "Charlson ME, Pompei P, Ales KL, MacKenzie CR. A new method of classifying prognostic comorbidity in longitudinal studies: development and validation. J Chronic Dis. 1987; 40(5): 373383", "ArticleIdList": ["3558716"]}, {"Citation": "Daugirdas JT. Second generation logarithmic estimates of single-pool variable volume Kt/V: an analysis of error. J Am Soc Nephrol. 1994; 4(5): 1205\u20131213.", "ArticleIdList": ["8305648"]}, {"Citation": "Kopple JD, National Kidney Foundation K/DOQI Work Group. The National Kidney Foundation K/DOQI clinical practice guidelines for dietary protein intake for chronic dialysis patients. Am J KidneyDis. 2001; 38: 68\u201373.", "ArticleIdList": ["11576926"]}, {"Citation": "Szeto CC, Ching-Ha KB, Ka-Bik L, Mac-Moune LF, Cheung-Lung CP, Gang W, et al.\nMicro-RNA expression in the urinary sediment of patients with chronic kidney diseases. Dis Markers. 2012; 33(3):137\u201344. doi: 10.3233/DMA-2012-0914", "ArticleIdList": ["10.3233/DMA-2012-0914", "PMC3810778", "22960330"]}, {"Citation": "Gupta S.K, Bang C, Thum T. Circulating microRNAs as biomarkers and potential paracrine mediators of cardiovascular disease. Circ Cardiovasc Genet. 2010; 3(5):484\u20138. doi: 10.1161/CIRCGENETICS.110.958363\n", "ArticleIdList": ["10.1161/CIRCGENETICS.110.958363", "20959591"]}, {"Citation": "Zampetaki A, Willeit P, Drozdov I, Kiechl S, Mayr M. Profiling of circulating micrornas: from single biomarkers to rewired networks. Cardiovasc Res. 2012; 93(4):555\u201362. doi: 10.1093/cvr/cvr266\n", "ArticleIdList": ["10.1093/cvr/cvr266", "PMC3291086", "22028337"]}, {"Citation": "Zbroch E, Malyszko J, Malyszko JS, Koc-Zorawska E, Mysliwiec M. Renalase, a novel enzyme involved in blood pressure regulation, is related to kidney function but not to blood pressure in hemodialysis patients. Kidney Blood Press Res. 2012; 35(6):395\u20139. doi: 10.1159/000338178\n", "ArticleIdList": ["10.1159/000338178", "22539018"]}, {"Citation": "Desir GV. Renalaseis a novel renal hormone that regulates cardiovascular function. J Am Soc Hypertens. 2007; 1(2):99\u2013103. doi: 10.1016/j.jash.2006.12.001\n", "ArticleIdList": ["10.1016/j.jash.2006.12.001", "20409839"]}, {"Citation": "Desir GV, Peixoto AJ. Renalase in hypertension and kidneydisease. Nephrol Dial Transplant. 2014; 29(1):22\u20138. doi: 10.1093/ndt/gft083\n", "ArticleIdList": ["10.1093/ndt/gft083", "24137013"]}, {"Citation": "Malyszko J, Koc-Zorawska E, Zorawski M, Kozminski P, Zbroch E, Rysz J, et al. Renalase is removed by kidneys and during dialysis\u2014excess related to CKD complications? CurrVascPharmacol. 2015; 13(1):134\u201340.", "ArticleIdList": ["25515790"]}, {"Citation": "Malyszko J, Malyszko JS, Mikhailidis DP, Rysz J, Zorawski M, Banach M. Hypertension and kidney disease: is renalase a new player or an innocent bystander?\nJ Hypertens. 2012; 30(3):457\u201362. doi: 10.1097/HJH.0b013e32834f0bb7\n", "ArticleIdList": ["10.1097/HJH.0b013e32834f0bb7", "22227817"]}, {"Citation": "Beaupre BA, Hoag MR, Moran GR. Renalase does not catalyze the oxidation of catecholamines. Arch Biochem Biophys. 2015; 579:62\u20136. doi: 10.1016/j.abb.2015.05.016\n", "ArticleIdList": ["10.1016/j.abb.2015.05.016", "26049000"]}, {"Citation": "Eikelis N, Hennebry SC, Lambert GW, Schlaich MP. Does renalase degrade catecholamines?\nKidney Int. 2011; 79(12):1380\ndoi: 10.1038/ki.2011.90\n", "ArticleIdList": ["10.1038/ki.2011.90", "21625261"]}, {"Citation": "Wang F, Zhang G, Xing T, Lu Z, Li J, Peng C, et al.\nRenalase contributes to the renal protection of delayed ischaemic preconditioning via the regulation of hypoxia-inducible factor-1\u03b1. J Cell Mol Med. 2015; 19(6):1400\u20139. doi: 10.1111/jcmm.12527\n", "ArticleIdList": ["10.1111/jcmm.12527", "PMC4459853", "25781495"]}, {"Citation": "Moran GR. The catalytic function of renalase: A decade of phantoms. Biochim Biophys Acta. 2016; 1864(1):177\u201386. doi: 10.1016/j.bbapap.2015.04.010\n", "ArticleIdList": ["10.1016/j.bbapap.2015.04.010", "25900362"]}, {"Citation": "Beaupre BA, Carmichael BR, Hoag MR, Shah DD, Moran GR. Renalase is an \u03b1-NAD(P)H oxidase/anomerase. J Am Chem Soc. 2013; 135(37):13980\u20137. doi: 10.1021/ja407384h\n", "ArticleIdList": ["10.1021/ja407384h", "23964689"]}, {"Citation": "Quelhas-Santos J, Serr\u00e3o MP, Soares-Silva I, Fernandes-Cerqueira C, Sim\u00f5es-Silva L, Pinho MJ, et al.\nRenalase regulates peripheral and central dopaminergic activities. Am J Physiol Renal Physiol. 2015; 308(2):F84\u201391. doi: 10.1152/ajprenal.00274.2014\n", "ArticleIdList": ["10.1152/ajprenal.00274.2014", "PMC4338928", "25411385"]}, {"Citation": "Li G, Xu J, Wang P, Velazquez H, Li Y, Wu Y, et al.\nCatecholamines regulate the activity, secretion, and synthesis of renalase. Circulation. 2008; 117(10):1277\u201382. doi: 10.1161/CIRCULATIONAHA.107.732032\n", "ArticleIdList": ["10.1161/CIRCULATIONAHA.107.732032", "18299506"]}, {"Citation": "Wang F, Li J, Xing T, Xie Y, Wang N. Serum renalase is related to catecholamine levels and renal function. Clin Exp Nephrol. 2015; 19(1):92\u20138. doi: 10.1007/s10157-014-0951-8\n", "ArticleIdList": ["10.1007/s10157-014-0951-8", "24590362"]}, {"Citation": "Kalyani A, Sonawane PJ, Khan AA, Subramanian L, Ehret GB, Mullasari AS, et al.\nPost-Transcriptional Regulation of Renalase Gene by miR-29 and miR-146 MicroRNAs: Implications for Cardiometabolic Disorders. J Mol Biol. 2015; 427(16):2629\u201346. doi: 10.1016/j.jmb.2015.07.003\n", "ArticleIdList": ["10.1016/j.jmb.2015.07.003", "26165231"]}, {"Citation": "Martino F, Lorenzen J, Schmidt J, Schmidt M, Broll M, G\u00f6rzig Y, et al.\nCirculating MicroRNAs Are Not Eliminated by Hemodialysis. PLoS One. 2012; 7(6):e38269\ndoi: 10.1371/journal.pone.0038269\n", "ArticleIdList": ["10.1371/journal.pone.0038269", "PMC3371001", "22715378"]}, {"Citation": "Emilian C, Goretti E, Prospert F, Pouthier D, Duhoux P, Gilson G. MicroRNAs in patients on chronic hemodialysis (MINOS study). Clin J Am Soc Nephrol. 2012; 7(4):619\u201323. doi: 10.2215/CJN.10471011\n", "ArticleIdList": ["10.2215/CJN.10471011", "PMC3315339", "22344502"]}, {"Citation": "Neal CS, Michael MZ, Pimlott LK, Yong TY, Li JY, Gleadle JM. Circulating microRNA expression is reduced in chronic kidney disease. Nephrol Dial Transplant. 2011; 26(11):3794\u2013802. doi: 10.1093/ndt/gfr485\n", "ArticleIdList": ["10.1093/ndt/gfr485", "21891774"]}, {"Citation": "Wang H, Peng W, Shen X, Huang Y, Ouyang X, Dai Y. Circulating levels of inflammation-associated miR-155 and endothelial-enriched miR-126 in patients with end-stage renal disease. Braz J Med. Biol Res. 2012; 45(12):1308\u201314. doi: 10.1590/S0100-879X2012007500165", "ArticleIdList": ["10.1590/S0100-879X2012007500165", "PMC3854222", "23070235"]}, {"Citation": "Metzinger-Le Meuth V, M'Baya-Moutoula E, Taibi F, Massy Z, Metzinger L. Implication of MicroRNAs in the Pathophysiology of Cardiac and Vascular Smooth Muscle Cells, Current Basic and Pathological Approaches to the Function of Muscle Cells and Tissues\u2014From Molecules to Humans, Sugi H, InTech, 2012; 17(3):183\u2013206. doi: 10.5772/47770", "ArticleIdList": ["10.5772/47770"]}, {"Citation": "Sonkoly E, St\u00e5hle M, Pivarcsi A. MicroRNAs and immunity: novel players in the regulation of normal immune function and inflammation. Semin Cancer Biol. 2008; 18(2):131\u201340. doi: 10.1016/j.semcancer.2008.01.005\n", "ArticleIdList": ["10.1016/j.semcancer.2008.01.005", "18291670"]}, {"Citation": "Sheedy FJ, O'Neill LA. Adding fuel to fire: microRNAs as a new class of mediators of inflammation. Ann Rheum Dis. 2008; 67(3): 50\u20135. doi: 10.1136/ard.2008.100289\n", "ArticleIdList": ["10.1136/ard.2008.100289", "19022814"]}, {"Citation": "Quinn SR, O'Neill LA. A trio of microRNAs that control Toll-like receptor signalling. IntImmunol. 2011; 23(7):421\u20135. doi: 10.1093/intimm/dxr034\n", "ArticleIdList": ["10.1093/intimm/dxr034", "21652514"]}, {"Citation": "Zbroch E, Ma\u0142yszko J, Ma\u0142yszko J, Koc-\u017b\u00f3rawska E, My\u015bliwiec M. Renalase, kidney function, and markers of endothelial dysfunction in renal transplant recipients. Pol Arch Med. Wewn. 2012; 122(1\u20132):40\u20134.", "ArticleIdList": ["22237745"]}, {"Citation": "Hao Y, Zhou Q, Ma J, Zhao Y, Wang S. miR-146a is upregulated during retinal pigment epithelium (RPE)/choroid aging in mice and represses IL-6 and VEGF-A expression in RPE cells. J Clin Exp Ophthalmol. 2016; 7(3): 562\u2013574. doi: 10.4172/2155-9570.1000562", "ArticleIdList": ["10.4172/2155-9570.1000562", "PMC5130286", "27917303"]}, {"Citation": "Olivieri F, Lazzarini R, Recchioni R, Marcheselli F, Rippo MR, Di Nuzzo S, et al.\nMiR-146a as marker of senescence-associated pro-inflammatory status in cells involved in vascular remodelling. Age (Dordr). 2013; 35(4): 1157\u20131172. doi: 10.1007/s11357-012-9440-8", "ArticleIdList": ["10.1007/s11357-012-9440-8", "PMC3705128", "22692818"]}, {"Citation": "Kutty RK, Nagineni CN, Samuel W, Vijayasarathy C, Jaworski C, Duncan T, et al. Differential regulation of microRNA-146a and microRNA-146b-5p in human retinal pigment epithelial cells by interleukin-1\u03b2, tumor necrosis factor-\u03b1, and interferon-\u03b3. Mol Vis. 2013; 3:19:737\u201350", "ArticleIdList": ["PMC3626297", "23592910"]}, {"Citation": "Stanczyk J, Pedrioli DM, Brentano F, Sanchez-Pernaute O, Kolling C, Gay RE, et al.\nAltered expression of MicroRNA in synovial fibroblasts and synovial tissue in rheumatoid arthritis. Arthritis Rheum\n2008; 58:1001\u20131009. doi: 10.1002/art.23386", "ArticleIdList": ["10.1002/art.23386", "18383392"]}, {"Citation": "Taganov KD, Boldin MP, Chang KJ, Baltimore D. NF-kappaB-dependent induction of microRNA miR-146, an inhibitor targeted to signaling proteins of innate immune responses. Proc Natl Acad Sci USA\n2006; 103:12481\u201312486. doi: 10.1073/pnas.0605298103", "ArticleIdList": ["10.1073/pnas.0605298103", "PMC1567904", "16885212"]}, {"Citation": "Bhaumik D, Scott GK, Schokrpur S, Patil CK, Orjalo AV, Rodier F, et al.\nMicroRNAs miR-146a/b negatively modulate the senescence-associated inflammatory mediators IL-6 and IL-8. Aging (Albany NY). 2009; 1(4):402\u201311. doi: 10.18632/aging.100042", "ArticleIdList": ["10.18632/aging.100042", "PMC2818025", "20148189"]}, {"Citation": "Taganov KD, Boldin MP, Baltimore D. MicroRNAs and immunity: tiny players in a big field. Immunity. 2007; 26(2):133\u2013137. doi: 10.1016/j.immuni.2007.02.005", "ArticleIdList": ["10.1016/j.immuni.2007.02.005", "17307699"]}]}], "History": [{"Year": "2016", "Month": "11", "Day": "2"}, {"Year": "2017", "Month": "5", "Day": "25"}, {"Year": "2017", "Month": "6", "Day": "15", "Hour": "6", "Minute": "0"}, {"Year": "2017", "Month": "6", "Day": "15", "Hour": "6", "Minute": "0"}, {"Year": "2017", "Month": "9", "Day": "16", "Hour": "6", "Minute": "0"}, {"Year": "2017", "Month": "6", "Day": "14"}], "PublicationStatus": "epublish", "ArticleIdList": ["28614373", "PMC5470705", "10.1371/journal.pone.0179218", "PONE-D-16-43570"]}}]}